title: Prevention of bone resorption by intake of phytoestrogens in postmenopausal women: a meta-analysis.
abstract: Phytoestrogens as selective estrogen receptor modulators like compounds may consider as a therapeutic option in osteoporosis. In this regard, the effect of phytoestrogens on bone biomarkers was examined in several trials which their results are controversial. We aimed this meta-analysis to evaluate the net effect of phytoestrogens on bone markers. A thorough search was conducted from 2000 to 2010 in English articles. All randomized clinical trials were reviewed, and finally, 11 eligible randomized clinical trials were selected for meta-analysis. Totally 1,252 postmenopausal women were enrolled in the study by considering the changes of pyridinoline (Pyd), desoxypyridinoline (Dpyd), bone alkaline phosphatase, and osteocalcin concentrations in urine and serum after phytoestrogens consumption. The urine Pyd and Dpyd levels decreased significantly in phytoestrogens consumers. Effect size and effect size for weighted mean difference of urine Pyd levels showed -1.229171 (95% confidence interval (CI) = -1.927639 to -0.530703) and -9.780623 (95% CI = -14.240401 to -5.320845), respectively, a significant results in comparison to control group and significant results for Dpyd -0.520132 (95% CI = -0.871988 to -0.168275) and -0.818582 (95% CI = -1.247758 to -0.389407), respectively. Meta-analysis indicates that phytoestrogens intake can prevent bone resorption, but its benefits on bone formation are not significant. This favorable effect was observed in low doses and in at least 3 weeks of phytoestrogens intake.
authors.affiliation: Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences, 16 Azar Ave, Tehran, Iran. poonehsalari@gmail.com
authors.forename: Pooneh
authors.initials: P
authors.lastname: Salari Sharif
authors.forename: Shekoufeh
authors.initials: S
authors.lastname: Nikfar
authors.forename: Mohammad
authors.initials: M
authors.lastname: Abdollahi
mesh_terms: D015415:Biomarkers / Q000032:analysis; D001862:Bone Resorption / Q000517:prevention & control*; D005260:Female; D006801:Humans; D010012:Osteogenesis / Q000187:drug effects; D010024:Osteoporosis / Q000188:drug therapy*; D048789:Phytoestrogens / Q000494:pharmacology / Q000627:therapeutic use*; D017698:Postmenopause; D016032:Randomized Controlled Trials as Topic; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D048789:Phytoestrogens; D020845:Selective Estrogen Receptor Modulators
references.citation: Phytother Res. 2003 Feb;17(2):112-9
references.pmid: 12601671
references.citation: Proc Nutr Soc. 2003 Nov;62(4):877-87
references.pmid: 15018488
references.citation: Phytochemistry. 2001 Apr;56(7):733-9
references.pmid: 11314961
references.citation: Eur J Clin Nutr. 2008 Feb;62(2):155-61
references.pmid: 17392695
references.citation: J Bone Miner Res. 2002 Oct;17(10):1904-12
references.pmid: 12369794
references.citation: J Bone Miner Res. 2002 Jan;17(1):11-4
references.pmid: 11771656
references.citation: Menopause. 2007 May-Jun;14(3 Pt 1):481-8
references.pmid: 17213752
references.citation: J Bone Miner Res. 1996 Mar;11(3):337-49
references.pmid: 8852944
references.citation: J Nutr. 2001 Mar;131(3):723-8
references.pmid: 11238750
references.citation: J Clin Endocrinol Metab. 2003 Mar;88(3):1048-54
references.pmid: 12629084
references.citation: Age (Dordr). 2010 Jun;32(2):179-86
references.pmid: 19967563
references.citation: Am J Clin Nutr. 2004 Feb;79(2):326-33
references.pmid: 14749241
references.citation: J Clin Endocrinol Metab. 2004 Jan;89(1):188-92
references.pmid: 14715848
references.citation: Endocr J. 2003 Oct;50(5):613-9
references.pmid: 14614218
references.citation: J Womens Health Gend Based Med. 2002 Jan-Feb;11(1):53-60
references.pmid: 11860725
references.citation: Curr Med Res Opin. 2005 Jul;21(7):1015-26
references.pmid: 16004668
references.citation: JAMA. 2002 Jul 17;288(3):321-33
references.pmid: 12117397
references.citation: Inflamm Allergy Drug Targets. 2009 Jul;8(3):169-75
references.pmid: 19601876
references.citation: Arch Intern Med. 2004 May 24;164(10):1108-12
references.pmid: 15159268
references.citation: JAMA. 1998 Aug 19;280(7):605-13
references.pmid: 9718051
references.citation: J Clin Endocrinol Metab. 2009 Oct;94(10):3798-805
references.pmid: 19584189
references.citation: J Womens Health (Larchmt). 2004 Nov;13(9):1000-7
references.pmid: 15665657
references.citation: J Am Coll Nutr. 2002 Dec;21(6):560-3
references.pmid: 12480802
references.citation: Eur J Nutr. 2006 Sep;45(6):327-34
references.pmid: 16763748
references.citation: JAMA. 2004 Jul 7;292(1):65-74
references.pmid: 15238592
references.citation: Phytochemistry. 2003 May;63(2):209-15
references.pmid: 12711143
references.citation: Climacteric. 2007 Jun;10(3):257-63
references.pmid: 17487653
references.citation: Proc Soc Exp Biol Med. 1998 Mar;217(3):345-50
references.pmid: 9492346
references.citation: Biochem J. 1981 Sep 1;197(3):759-62
references.pmid: 7325985
references.citation: J Bone Miner Res. 2007 Jul;22(7):1072-9
references.pmid: 17419678
references.citation: Climacteric. 2005 Dec;8(4):371-9
references.pmid: 16390772
references.citation: J Womens Health Gend Based Med. 2002 Jan-Feb;11(1):69-78
references.pmid: 11860727
references.citation: J Am Coll Nutr. 2002 Apr;21(2):97-102
references.pmid: 11999549
references.citation: Bone. 2009 May;44(5):948-53
references.pmid: 19168161
references.citation: Clin Endocrinol (Oxf). 2003 Jun;58(6):704-9
references.pmid: 12780746
references.citation: Clin Chem. 1981 Dec;27(12):2002-7
references.pmid: 7307252
references.citation: Med Sci Monit. 2008 Mar;14(3):RA37-44
references.pmid: 18301367
references.citation: Bone. 2006 May;38(5):686-93
references.pmid: 16406762
references.citation: J Clin Endocrinol Metab. 2000 Sep;85(9):3043-8
references.pmid: 10999783